-
Pharmaceutical Companies have been Engaged in the R&D of BET Inhibitor with Great Efforts
PharmaSources/Ye Fenghong
November 01, 2021
Recently, CDE official website showed that the clinical trial application of Betta Pharmaceuticals for BPI-23314 tablets, a type 1 new drug, has been given the implied license.
-
Chinese Developed New Drug Exploits the Field of Diabetes
PharmaSources/Yi
November 01, 2021
Recently, the marketing application of chiglitazar sodium tablets, a new type 1 drug of Chipscreen (the relevant acceptance No. is CXHS1900032), has entered the administrative examination and approval stage, and it is expected that...
-
Small Molecule and Great Potential: Oral Small Molecule COVID-19 Pharmaceutical Chemicals
PharmaSources/Xiaoyaowan
October 28, 2021
Recently, MSD announced to initiate the Phase III clinical trial of its oral small molecule COVID-19 drug - Molnupiravir (MK-4482).
-
New Progress of Key Chinese COVID-19 Drugs under Research
PharmaSources/Xiaoyaowan
October 28, 2021
With the wide spread of Delta mutant worldwide, the COVID-19 infection situation is worrisome. In addition to vaccination for prevention, drug therapy can alleviate the disease deterioration...
-
Analysis on the Layout of Innovative Drugs in China and Globally
PharmaSources/Zhulikou431
October 27, 2021
Recently, there is a saying in the pharmaceutical industry: not all innovative drugs have a future. This saying reminds me of the lyrics - wild lilies also have spring.
-
New Breakthrough in Epilepsy Drug: First Generic Drug of Eslicarbazepine Will Be Approved Soon
PharmaSources/Yi
October 27, 2021
A few days ago, the marketing application (the relevant acceptance No. is CYHS2100147) of type 3 generic drugs "Eslicarbazepine Acetate" submitted by Yangtze River Pharmaceutical Group Beijing Haiyan Pharmaceutical Co., Ltd....
-
With the transaction exceeding 300 million US dollars reached, how is the exploration of Chinese inhibitor KRAS G12C?
PharmaSources/Yefenghong
September 14, 2021
On September 2, Innovent announced that it had reached a global exclusive licensing agreement with Genfleet. Innovent, as an exclusive partner of Genfleet, will obtain the right to develop and commercialize GFH925...
-
Research and Application Status of Kojic Acid - the Raw Material of Skin Whitening Cosmetics
PharmaSources/Xiaonisha
September 14, 2021
Kojic acid is also called aspergillic acid with its chemical name of 5-hydroxy-2-hydroxymethyl-4H-pyran-4-one, and its chemical structural formula is as follows.
-
A New Target in ADC: Nectin-4
PharmaSources/Yefenghong
September 14, 2021
Recently, the application for clinical trail of Mabwell's ADC drug (9MW2821) targeting Nectin-4 has been accepted by NMPA. It is the first time that domestic enterprise enters the IND stage with the same target drug.
-
Medicinal Value and Supply and Demand Status of Sodium Bicarbonate
PharmaSources/Yuntian
September 09, 2021
Sodium bicarbonate has been used clinically for over 200 years. Sodium carbonate was originally used as an antacid to neutralize excessive gastric acid.